Economic and National Security Threats Create Lithium Bonanza
The U.S. and China are fighting for new sources of lithium – the linchpin of clean energy. Lithium mining operations have been declared a national emergency. Biden has ordered America's lithium supply chain to be strengthened and investors in lithium exploration companies are rejoicing. We may be entering a decades-long lithium bull run. You don't want to miss it.
Click here for the full story.
Scott William Drake, insider at ViewRay
Scott William Drake Insider Alerts

Get notified the next time Scott William Drake buys or sells ViewRay stock. Enter your email address below to get our daily insider buying and selling report.

Scott William Drake Insider Information

CEO of ViewRay
Scott William Drake serves as Independent Chairman of the Board of the Company. Mr. Drake has served as one of our directors since September 2013 and as the Chairman of the Board since May 2018. Mr. Drake currently serves as the President and Chief Executive Officer of ViewRay, a publicly-held medical device company with global operations in radiation therapy and imaging technologies. Previously, Mr. Drake was the President, Chief Executive Officer, and member of the Board of Directors of The Spectranetics Corporation from 2011 to 2017. Spectranetics, acquired by Royal Philips in August of 2017, was a publicly-held medical device company that developed, manufactured and distributed single-use medical devices used in minimally invasive procedures within the cardiovascular system. Prior to joining Spectranetics, Mr. Drake served as Senior Vice President, Operations, of DaVita, Inc., a leading U.S. provider of kidney care and dialysis. Previously, Mr. Drake spent 17 years in several leadership positions within numerous healthcare business units at Covidien. From 2006 to 2009, he was President of Covidien’s Respiratory and Monitoring Solutions Global Business Unit, a $1.5 billion business with 8,000 employees. Mr. Drake has also served on the Board of Directors for The Zayo Group Holdings, Inc. since November 2018. Mr. Drake is Chairperson of the AdvaMed Radiation Therapy Sector and a board member of the Medical Device Manufacturers Association (MDMA). Mr. Drake earned a B.S. in Business Administration from Miami University of Ohio.

What is Scott William Drake's net worth?

The estimated net worth of Scott William Drake is at least $418,304.25 as of May 7th, 2021. Mr. Drake owns 79,677 shares of ViewRay stock worth more than $418,304 as of November 30th. This net worth approximation does not reflect any other investments that Mr. Drake may own. Learn More.

How do I contact Scott William Drake?

The corporate mailing address for Mr. Drake and other ViewRay executives is 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146. ViewRay can also be reached via phone at (440) 703-3210 and via email at [email protected]

Has Scott William Drake been buying or selling shares of ViewRay?

In the last ninety days, Scott William Drake has bought $499,996.00 in shares of ViewRay stock. Most recently, on Friday, November 19th, Scott William Drake bought 89,285 shares of ViewRay stock. The stock was acquired at an average cost of $5.60 per share, with a total value of $499,996.00.

Who are ViewRay's active insiders?

ViewRay's insider roster includes Scott Drake (CEO), and Zachary Stassen (CFO).

Are insiders buying or selling shares of ViewRay?

During the last twelve months, ViewRay insiders bought shares 3 times. They purchased a total of 147,142 shares worth more than $812,795.20. During the last twelve months, insiders at the sold shares 2 times. They sold a total of 8,300,000 shares worth more than $53,751,000.00. The most recent insider tranaction occured on November, 19th when CFO Zachary William Stassen bought 17,857 shares worth more than $99,999.20. Insiders at ViewRay own 4.8 % of the company.

Information on this page was last updated on 11/19/2021.

Scott William Drake Insider Trading History at ViewRay

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/19/2021Buy89,285$5.60$499,996.00View SEC Filing Icon  
11/10/2020Buy155,000$3.23$500,650.00View SEC Filing Icon  
8/13/2019Buy131,260$3.81$500,100.60View SEC Filing Icon  
11/13/2018Buy60,000$6.47$388,200.00View SEC Filing Icon  
See Full Table

Scott William Drake Buying and Selling Activity at ViewRay

This chart shows Scott William Drake's buying and selling at ViewRay by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ViewRay Company Overview

ViewRay logo
ViewRay, Inc. designs, manufactures and markets magnetic resonance imaging (MRI) system. It develops MRIdian to address the limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that defines the tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova in 2004 and is headquartered in Oakwood Village, OH.
Read More

Today's Range

Now: $5.25
Low: $5.23
High: $5.58

50 Day Range

MA: $6.52
Low: $5.25
High: $7.59

2 Week Range

Now: $5.25
Low: $3.54
High: $8.25


1,789,272 shs

Average Volume

1,524,167 shs

Market Capitalization

$864.90 million

P/E Ratio


Dividend Yield



Investor Alert: Argentina Loaded With "White Gold" Opportunity
Experts expect the global lithium market to grow by 500% due to the explosion of electric vehicles and green energy. And one small-cap company just snagged a large lithium deposit in a renowned South American location.
Read about this once-in-a-lifetime opportunity